JMP Group Announces Addition of Shawn Cross to Investment Banking Division
September 18 2018 - 6:45AM
Business Wire
Managing Director to Focus on Biotechnology and
Biopharmaceuticals
JMP Group LLC (NYSE: JMP), an investment banking and alternative
asset management firm, announced today that Shawn Cross has joined
JMP Securities as a managing director in its healthcare investment
banking group. Based in the firm’s San Francisco office, Mr. Cross
will concentrate on the biotechnology and biopharmaceutical
sectors.
“Shawn brings over two decades of experience to JMP Securities’
healthcare group,” said Carter Mack, president of JMP Group. “He
has held senior investment banking positions at top Wall Street
firms and has also spent time in executive roles in industry.
Shawn’s extensive knowledge of the biotech and biopharma spaces, as
well as the associated capital markets and M&A landscapes, will
help position our highly regarded life sciences franchise for even
greater success.”
Prior to joining JMP Securities, Mr. Cross was chairman and
chief executive officer of GT Biopharma, a clinical-stage
immuno-oncology company. Mr. Cross was previously a managing
director in healthcare investment banking at Deutsche Bank
Securities, where he led the biotechnology coverage effort, after
working as a managing director and head of biopharmaceutical
investment banking at Well Fargo Securities. Earlier, Mr. Cross
served in healthcare investment banking roles at Thomas Weisel
Partners and Alex. Brown & Sons. Before commencing his Wall
Street career, he performed cell cycle cancer research in the
division of gastroenterology at University of Washington Medical
School. Mr. Cross holds an MBA from Columbia Business School and a
BS from University of California, Los Angeles.
JMP Securities is a full-service, middle-market investment bank
with a healthcare platform consisting of six investment banking
calling officers, a senior healthcare capital markets professional,
and six equity research analysts covering biotechnology,
biopharmaceuticals, medical devices and supplies, and healthcare
services and facilities. The firm’s healthcare investment banking
group executed 38 capital raising and strategic advisory
transactions with an aggregate value of $4.1 billion in 2017
and has completed 35 such transactions in 2018 to date.
About JMP Group
JMP Group LLC is a diversified capital markets firm that
provides investment banking, equity research, and sales and trading
services to corporate and institutional clients as well as
alternative asset management products and services to institutional
and high-net-worth investors. JMP Group conducts its investment
banking and research, sales and trading activities through JMP
Securities; its hedge fund, venture and private capital, and credit
management activities through Harvest Capital Strategies, JMP Asset
Management and JMP Credit Advisors; and the management of Harvest
Capital Credit Corporation (NASDAQ: HCAP), a business development
company, through HCAP Advisors. For more information, visit
www.jmpg.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180918005095/en/
Investor Relations ContactJMP Group LLCAndrew Palmer,
415-835-8978apalmer@jmpg.comorMedia Relations ContactsDukas
Linden Public Relations, Inc.Zach Leibowitz,
646-722-6528zach@dlpr.comAlyssa Noud,
646-722-6525alyssa@dlpr.com
JMP (NYSE:JMP)
Historical Stock Chart
From Mar 2024 to Apr 2024
JMP (NYSE:JMP)
Historical Stock Chart
From Apr 2023 to Apr 2024